{"DataElement":{"publicId":"7171860","version":"1","preferredName":"Metastatic Diagnosis Cholangiocarcinoma Risk Factor History Category","preferredDefinition":"An individual's attribute, characteristic or exposure that increases the likelihood of developing metastatic disease that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct.","longName":"7115532v1.0:7114227v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7115532","version":"1","preferredName":"Metastatic Diagnosis Risk Factor History","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease._A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","longName":"6841515v1.0:7115530v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"6841515","version":"1","preferredName":"Metastatic Diagnosis","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease.","longName":"C162221","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Diagnosis","conceptCode":"C162221","definition":"Any diagnosis indicating the presence of metastatic disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFAFAB2-E712-5A45-E053-F662850A0775","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7115530","version":"1","preferredName":"Risk Factor History","preferredDefinition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","longName":"C157153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor History","conceptCode":"C157153","definition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB73A5A-E3CE-6CE2-E053-F662850AF2CB","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB73A5A-E3DF-6CE2-E053-F662850AF2CB","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-06-14","changeDescription":"6/14/20 jk added CPTAC ESCA Baseline CSI. 2/14/20 jk Released per CPTAC SME (Linda) review and approval. 12/27/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114227","version":"1","preferredName":"Cholangiocarcinoma Risk Factor History Category","preferredDefinition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas._A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)_A grouping of items based on some commonality or by user defined characteristics.","longName":"7114227v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hepatitis B","valueDescription":"Hepatitis B Infection","ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D7FF-6FE4-E053-F662850A2278","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Hepatitis C","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D809-6FE4-E053-F662850A2278","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Non-Alcoholic Fatty Liver Disease","valueDescription":"Nonalcoholic Fatty Liver Disease","ValueMeaning":{"publicId":"3171842","version":"1","preferredName":"Nonalcoholic Fatty Liver Disease","longName":"3171842","preferredDefinition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Fatty Liver Disease","conceptCode":"C84444","definition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-016C-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D813-6FE4-E053-F662850A2278","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"None","valueDescription":"Risk Factor History Negative","ValueMeaning":{"publicId":"7114215","version":"1","preferredName":"Risk Factor History Negative","longName":"7114215","preferredDefinition":"The determination that an individual's risk factor history is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor History Negative","conceptCode":"C159672","definition":"The determination that an individual's risk factor history is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB1232A-EC9A-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D81D-6FE4-E053-F662850A2278","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D827-6FE4-E053-F662850A2278","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Unknown: Could not be determined or unsure.","valueDescription":"Indeterminate or Unknown","ValueMeaning":{"publicId":"6841632","version":"1","preferredName":"Indeterminate or Unknown","longName":"6841632","preferredDefinition":"An indication that something is indeterminate or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate or Unknown","conceptCode":"C157157","definition":"An indication that something is indeterminate or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFB6B26-0C86-5A31-E053-F662850A5C7D","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB144CE-D831-6FE4-E053-F662850A2278","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Thorotrast Contrast Exposure","valueDescription":"Thorotrast Exposure","ValueMeaning":{"publicId":"4618012","version":"1","preferredName":"Thorotrast Exposure","longName":"4618012","preferredDefinition":"Exposure to thorotrast, which contains particles of the radioactive compound thorium dioxide, as a radiocontrast agent.  It is a carcinogenic compound, linked to the development of bile duct cancer, leukemia, and angiosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thorotrast Exposure","conceptCode":"C36187","definition":"Exposure to thorotrast, which contains particles of the radioactive compound thorium dioxide, as a radiocontrast agent. It is a carcinogenic compound, linked to the development of bile duct cancer, leukemia, and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CEBA-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-9086-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Liver Fluke Infestation","valueDescription":"Schistosomiasis","ValueMeaning":{"publicId":"3211429","version":"1","preferredName":"Schistosomiasis","longName":"3211429","preferredDefinition":"A parasitic infection caused by flukes of the genus Schistosoma. Signs and symptoms include fever, abdominal pain, eosinophilia and hepatosplenomegaly. If left untreated it may eventually cause liver damage leading to cirrhosis, bladder cancer and kidney failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schistosomiasis","conceptCode":"C35000","definition":"A parasitic infection caused by flukes of the genus Schistosoma. Signs and symptoms include fever, abdominal pain, eosinophilia and hepatosplenomegaly. If left untreated it may eventually cause liver damage leading to cirrhosis, bladder cancer and kidney failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FC87-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-9091-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Ulcerative Colitis","valueDescription":"Ulcerative Colitis","ValueMeaning":{"publicId":"4264977","version":"1","preferredName":"Ulcerative Colitis","longName":"4264977","preferredDefinition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulcerative Colitis","conceptCode":"C2952","definition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3D16-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-909C-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Crohn's Disease","valueDescription":"Crohn's Disease (CD)","ValueMeaning":{"publicId":"6650859","version":"1","preferredName":"Crohn's Disease (CD)","longName":"6650859","preferredDefinition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crohn Disease","conceptCode":"C2965","definition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82473C0D-C3D5-1361-E053-F662850A0559","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-90B1-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Smoking","valueDescription":"Smoking","ValueMeaning":{"publicId":"7171840","version":"1","preferredName":"Smoking","longName":"7171840","preferredDefinition":"The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Smoking","conceptCode":"C154329","definition":"The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC99208-90BE-4F30-E053-F662850A39B0","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-90D7-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Hepatolithiasis","valueDescription":"Hepatolithiasis","ValueMeaning":{"publicId":"4618016","version":"1","preferredName":"Hepatolithiasis","longName":"4618016","preferredDefinition":"The presence of solitary or multiple stones in the intrahepatic bile ducts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatolithiasis","conceptCode":"C119011","definition":"The presence of solitary or multiple stones in the intrahepatic bile ducts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CF3C-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-90E1-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Choledochal Cyst","valueDescription":"Choledochal Cyst","ValueMeaning":{"publicId":"4618017","version":"1","preferredName":"Choledochal Cyst","longName":"4618017","preferredDefinition":"Cystic dilatation of the hepatic duct or bile duct.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choledochal Cyst","conceptCode":"C2943","definition":"Cystic dilatation of the hepatic duct or bile duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CF74-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-90F6-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-9101-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-910C-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"},{"value":"Primary Sclerosing Cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EC99208-9117-4F30-E053-F662850A39B0","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7114226","version":"1","preferredName":"Cholangiocarcinoma Risk Factor History Category","preferredDefinition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.:A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO):A grouping of items based on some commonality or by user defined characteristics.","longName":"C4436:C157153:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk Factor History","conceptCode":"C157153","definition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB144CE-D7D6-6FE4-E053-F662850A2278","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB144CE-D7E7-6FE4-E053-F662850A2278","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"COLBERTM","dateModified":"2022-09-19","changeDescription":"2/17/20 jk obtained concepts; added remaining PVs.  12/27/19 jk created for CPTAC CHOL baseline CRF; need to add CHOL specific PVs.","administrativeNotes":"7/18/2022: fixed the box symbol in PV.wz  9/19/22 Released/Application bc CDE was released.  mr;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779538","version":"1","longName":"CHOL Baseline","context":"OCCPR"},{"publicId":"6779539","version":"1","longName":"CHOL Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"History of Risk Factors","type":"Preferred Question Text","description":"History of Risk Factors","url":null,"context":"OCCPR"},{"name":"CPTAC-PATH-1","type":"Alternate Question Text","description":"History of Select Risk Factors","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9EC9B64F-2815-6756-E053-F662850A8F46","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"COLBERTM","dateModified":"2022-09-19","changeDescription":"2/17/20 jk created for CPTAC CHOL baseline CRF.","administrativeNotes":"7/7/22 Added CSI CHOL Local Path. mr; 8/3/22 Added AQT per CRF/spreadsheet. mr; 9/19/22 Released/Qualified per jk; mr;","unresolvedIssues":null,"deletedIndicator":"No"}}